Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Astrazeneca plc crawled date : 2022 - 03 - 02 save search
New Drug Delivery Systems Market 2022-2026 | Rising Prevalence Of Chronic Diseases to Boost Growth | Technavio
Published: 2022-03-02 (Crawled : 19:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -6.92%
H: 1.86%
C: 1.86%
AZNCF | $138.24 -4.19% 800
|
Health Technology
|
| O: -5.26%
H: 0.0%
C: 0.0%
MDT | $79.445 0.32% 5.1M
|
Health Technology
|
| O: 1.86%
H: 0.0%
C: 0.0%
BAX | $39.47 -0.45% 0.0% 2.8M
|
Health Technology
|
| O: 0.28%
H: 0.54%
C: -0.33%
ABT | News | $107.4 2.02% 6.4M
|
Health Technology
|
| O: -0.01%
H: 0.0%
C: 0.0%
SNY | News | $46.385 2.19% 3M
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: 0.0%
AZN | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -2.63%
H: 0.9%
C: -0.3%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 2.3%
H: 0.0%
C: 0.0%
new drug drug liver system disease growth drug delivery
Genprex Announces First Patient Dosed in Phase 1/2 Acclaim-1 Clinical Trial of REQORSA™ Immunogene Therapy in Combination with Tagrisso® to Treat Non-Small Cell Lung Cancer
Published: 2022-03-02 (Crawled : 14:00) - biospace.com/
AZNCF | $138.24 -4.19% 800
|
Health Technology
|
| O: 0.37%
H: 2.02%
C: 2.02%
GNPX | $2.2194 35K
|
Health Technology
|
| O: 3.95%
H: 5.06%
C: -7.17%
AZN | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.62%
H: 0.0%
C: 0.0%
tagrisso gene therapy trial cel lung cancer phase 1 therapy cancer
JAK Inhibitors Market to Grow by USD 12.05 billion | Increasing Number of Awareness Campaigns to Boost Growth | Technavio
Published: 2022-03-01 (Crawled : 00:00) - prnewswire.com
AZNCF | $138.24 -4.19% 800
|
Health Technology
|
| O: 0.37%
H: 2.02%
C: 2.02%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.39%
H: 0.0%
C: 0.0%
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
|
| O: -1.17%
H: 0.68%
C: 0.68%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -1.55%
H: 0.0%
C: 0.0%
ABBV | News | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.22%
H: 2.4%
C: 1.27%
GLPG | $29.08 0.59% 82K
|
Health Technology
|
| O: -2.66%
H: 0.35%
C: -1.83%
CTIC | $9.09 0.05% 11M
|
Health Technology
|
| O: 6.03%
H: 13.88%
C: 12.71%
AZN | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.62%
H: 0.0%
C: 0.0%
growth
Gainers vs Losers
| 63% | 37% |
Top 10 Gainers
AGBA | News | $1.305 226.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
INSG | $3.03 25.21% 330K
|
Electronic Technology
KNW 4 | $0.59 -0.71% 18.64% 27K
|
Manufacturing
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
ASNS | $0.828 21.75% 17.86% 18K
|
UONE | $2.36 19.8% 16.53% 75K
|
Consumer Services
Your saved searches
Save your searches and get alerts when important news are released.